Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

UK homecare? No thanks!

Long-term NHS contracts make much of the UK homecare sector unattractive. Duke Street is trying to sell Baywater Healthcare, its COPD and sleep apnea business, and Bupa has been running the slide rule over its Bupa Home Healthcare arm.

Bid rumours

Which big lab group is up for sale? And which hospital chain has just been withdrawn after a failed auction? We report! Why not subscribe and find out?

EU cross-border directive changes little

Unless you are Danish, the likelihood of you getting treatment abroad under the EU cross border healthcare directive appears to be vanishingly small. We fillet a recent report and talk to expert academic Magda Rosenmuller.

Abraaj’s Global Healthcare Fund may miss $1bn target

Abraaj has raised $250m for its Global Healthcare Fund, but should make it to $400m, according to investor sources. A second close is likely at $750m but Abraaj is unlikely to hit the $1bn target it had planned in 2014.

Al Noor buys rehabilitation group Rochester Wellness

London stock exchange-quoted healthcare group Abu Dhabi-based Al Noor Hospitals has bought rehabilitation group Rochester Wellness, which provides homecare in the Dubai region, as well as impatient services in Dubai and Muscat.

Senior Assist to triple beds in Chile

Senior Assist, the Belgian elderly care group, expects its nursing home business in Chile to triple to 1,500 beds by 2018. The group has also opened homes in Turkey and Uruguay and is looking at Colombia, Russia and Thailand. We talk to Roderick Peters, CEO of Senior Assist Latin America about the Latin America market.

Advent buys 13% of Fleury

Private equity group Advent International has purchased a minority stake in quoted Brazilian diagnostics provider Grupo Fleury for an undisclosed fee. An inside source tells us there is no drag along. We also spoke to chairman Dr Marcos Bosi Ferraz about the deal and the impact of the recession on the private healthcare industry.

Interview: Helmut Schuehsler, Chairman & CEO, TVM Capital Healthcare Partners

In 25 years TVM Capital, the business where Schuehsler is at the helm, has invested over $1.5bn in life sciences. Yet, five years ago, he took the remarkable personal decision to move from Munich to Dubai and to build a completely new arm to invest in healthcare services in Emerging Markets. Since then, Dubai-based TVM Capital Healthcare Partners and co-investors have invested some $150m in five investments, ranging from Egypt to India. He is now raising a third fund of $300m for another dozen investments.

Find Us